Korean Drug sets up joint venture

Published: 2010-08-23 06:56:00

Updated: 2010-08-23 06:56:00

Korean Drug and BRC have joined forces with Australia based Medinc Co. to set up a joint venture company called “Reach 100 Plus N,” it was learned on August 17.

The newly established company is aiming to market anti-aging related pharmaceuticals.

"The partnership will pave the way for us to...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK